Resumen
We have identified several ligands with high binding affinities to the dopamine D3 receptor and excellent selectivity over the D2 and D1 receptors. CJ-1639 (17) binds to the D3 receptor with a K i value of 0.50 nM and displays a selectivity of >5000 times over D2 and D1 receptors in binding assays using dopamine receptors expressed in the native rat brain tissues. CJ-1639 binds to human D3 receptor with a K i value of 3.61 nM and displays over >1000-fold selectivity over human D1 and D2 receptors. CJ-1639 is active at 0.01 mg/kg at the dopamine D3 receptor in the rat and only starts to show a modest D2 activity at doses as high as 10 mg/kg. CJ-1639 is the most potent and selective D3 full agonist reported to date.
Idioma original | English (US) |
---|---|
Páginas (desde-hasta) | 620-625 |
Número de páginas | 6 |
Publicación | ACS Medicinal Chemistry Letters |
Volumen | 2 |
N.º | 8 |
DOI | |
Estado | Published - ago 11 2011 |
Publicado de forma externa | Sí |
ASJC Scopus subject areas
- Drug Discovery
- Biochemistry
- Organic Chemistry